Linked Life Data

15131558

Source:http://linkedlifedata.com/resource/pubmed/id/15131558

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2004-5-7
pubmed:abstractText
Thiazolidinediones have been shown to have an antiproliferative vascular effect in experimental models. We sought to study the effect of rosiglitazone on in-stent restenosis in patients with established type 2 diabetes.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1097-6744
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
147
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
e23
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:15131558-Administration, Oral, pubmed-meshheading:15131558-Adult, pubmed-meshheading:15131558-Aged, pubmed-meshheading:15131558-Cardiovascular Agents, pubmed-meshheading:15131558-Coronary Angiography, pubmed-meshheading:15131558-Coronary Restenosis, pubmed-meshheading:15131558-Diabetes Mellitus, Type 2, pubmed-meshheading:15131558-Diabetic Angiopathies, pubmed-meshheading:15131558-Double-Blind Method, pubmed-meshheading:15131558-Female, pubmed-meshheading:15131558-Hemoglobin A, Glycosylated, pubmed-meshheading:15131558-Humans, pubmed-meshheading:15131558-Hypoglycemic Agents, pubmed-meshheading:15131558-Male, pubmed-meshheading:15131558-Middle Aged, pubmed-meshheading:15131558-Plasminogen Activator Inhibitor 1, pubmed-meshheading:15131558-Stents, pubmed-meshheading:15131558-Thiazolidinediones
pubmed:year
2004
pubmed:articleTitle
Effect of rosiglitazone on restenosis after coronary stenting in patients with type 2 diabetes.
pubmed:affiliation
Division of Cardiology, University of Texas Medical Branch, Galveston, Texas, USA.
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, U.S. Gov't, P.H.S., Randomized Controlled Trial